Metric Finance
LearnFAQ
LearnFAQ

Learn / NUVB

NYSE: NUVB

Nuvation Bio (NUVB) stock, explained like you're 5

Nuvation Bio trades on the New York Stock Exchange under the ticker NUVB. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.

Ticker
NUVB
Exchange
New York Stock Exchange
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Small cap, about 1.8 billion dollars

Is Nuvation Bio a small, medium or large cap company?

No. Nuvation Bio is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 1.8 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Nuvation Bio makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves NUVB stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Nuvation Bio Inc. (NUVB) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • Nuvation Bio Inc. (NUVB) stock price, news, quote and history (Yahoo Finance Singapore)
  • JPMorgan initiates Nuvation Bio stock coverage with overweight rating (Investing.com)
  • Nuvation Bio Announces Proposed Convertible Senior Notes Offering (PR Newswire)
  • Nuvation Bio And 2 Top Penny Stocks To Watch (Simply Wall Street)

Follow NUVB in your daily brief

Each trading day at 5 PM ET we post what happened to Nuvation Bio and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow NUVB

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Nuvation Bio stock

What does Nuvation Bio do?

Nuvation Bio trades on the New York Stock Exchange under the ticker NUVB. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 1.8 billion dollars.

What is the ticker symbol for Nuvation Bio?

Nuvation Bio trades under the ticker NUVB on the New York Stock Exchange.

What is Nuvation Bio's market cap?

Nuvation Bio is a small cap stock with a market cap of about 1.8 billion dollars.

How does Nuvation Bio make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves NUVB stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow NUVB stock every day?

Add NUVB to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow NUVB daily

A free brief on Nuvation Bio and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare NUVB: NUVB vs NVS, NUVB vs AZN, NUVB vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed